Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Bone Marrow Transplantation
|
May 29, 2007
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection
P de Fabritiis, A Spagnoli, P Di Bartolomeo, et al.
Bone Marrow Transplantation
|
June 4, 2015
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update
W Arcese, A Picardi, S Santarone, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
November 13, 2013
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network
F Marchesi, A Mengarelli, F Giannotti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
August 1, 2016
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor
C Cerva, L Colagrossi, G Maffongelli, et al.
Haematologica
|
August 28, 2001
Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program
L Pagano, C Girmenia, L Mele, et al.
Bone Marrow Transplantation
|
December 13, 2016
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia
F Buccisano, L Maurillo, A Piciocchi, et al.
Journal of Bone Oncology
|
December 11, 2020
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?
O Annibali, M T Petrucci, D Santini, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Bone Marrow Transplantation
|
May 29, 2007
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection
P de Fabritiis, A Spagnoli, P Di Bartolomeo, et al.
Bone Marrow Transplantation
|
June 4, 2015
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update
W Arcese, A Picardi, S Santarone, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
November 13, 2013
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network
F Marchesi, A Mengarelli, F Giannotti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
August 1, 2016
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor
C Cerva, L Colagrossi, G Maffongelli, et al.
Haematologica
|
August 28, 2001
Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program
L Pagano, C Girmenia, L Mele, et al.
Bone Marrow Transplantation
|
December 13, 2016
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia
F Buccisano, L Maurillo, A Piciocchi, et al.
Journal of Bone Oncology
|
December 11, 2020
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?
O Annibali, M T Petrucci, D Santini, et al.
Page
of 4